ArticleJournal of virology2003

Intranasal vaccination using interleukin-12 and cholera toxin subunit B as adjuvants to enhance mucosal and systemic immunity to human immunodeficiency virus type 1 glycoproteins.

Diana I Albu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.